Last deal

$11.1K
Local Amount - CHF 10K

Amount

Grant

Stage

29.05.2023

Date

2

all rounds

$11.1K

Total amount

General

About Company
Muvon Therapeutics develops autologous cell therapies to restore skeletal muscle.

Industry

Sector :

Subsector :

Keywords :

Also Known As

MUVON

founded date

01.01.2020

Number of employees

Company Type

For Profit

Last funding type

Grant

IPO status

Private

Description

The Swiss biotech company has created a platform that offers treatment for stress urinary incontinence in women and diseases related to skeletal muscle damage or degradation. Muvon Therapeutics aims to facilitate regeneration of skeletal muscle tissue, supporting patients on their journey to a healthy life. The company can be contacted via mail, phone, or physical address.